Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chirantan Chatterjee

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature|November 4, 2025
Can AI predict and limit online hate?Chirantan Chatterjee
Social Science & Medicine (1982)|January 9, 2017
The role of physicians in prescribing irrational fixed-dose combination medicines in IndiaAjay Bhaskarabhatla, Chirantan Chatterjee
Journal of Health Economics|November 19, 2015
The consumer welfare implications of governmental policies and firm strategy in markets for medicinesChirantan Chatterjee, Kensuke Kubo, Viswanath Pingali
Social Science & Medicine (1982)|August 20, 2019
From courts to markets: New evidence on enforcement of pharmaceutical bans in IndiaChirantan Chatterjee, Debi Prasad Mohapatra, Manuel Estay
Research Policy|September 21, 2020
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabelingMatthew J Higgins, Xin Yan, Chirantan Chatterjee
Health Economics|February 2, 2023
Movies, stigma and choice: Evidence from the pharmaceutical industryMayank Aggarwal, Anindya S Chakrabarti, Chirantan Chatterjee
Social Science & Medicine (1982)|December 31, 2019
Did India's price control policy for coronary stents create unintended consequences?Sarang Deo, Hanu Tyagi, Chirantan Chatterjee, et al.
Health Policy and Planning|February 17, 2017
Mitigating regulatory impact: the case of partial price controls on metformin in IndiaAjay Bhaskarabhatla, Chirantan Chatterjee, Priyatam Anurag, et al.
Social Science & Medicine (1982)|November 28, 2017
Government health insurance and spatial peer effects: New evidence from IndiaChirantan Chatterjee, Radhika Joshi, Neeraj Sood, et al.
Review of Development Economics|August 9, 2022
Pandemics and technology engagement: New evidence from m-Health intervention during COVID-19 in IndiaSawan Rathi, Anindya S Chakrabarti, Chirantan Chatterjee, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature|November 4, 2025
Can AI predict and limit online hate?Chirantan Chatterjee
Social Science & Medicine (1982)|January 9, 2017
The role of physicians in prescribing irrational fixed-dose combination medicines in IndiaAjay Bhaskarabhatla, Chirantan Chatterjee
Journal of Health Economics|November 19, 2015
The consumer welfare implications of governmental policies and firm strategy in markets for medicinesChirantan Chatterjee, Kensuke Kubo, Viswanath Pingali
Social Science & Medicine (1982)|August 20, 2019
From courts to markets: New evidence on enforcement of pharmaceutical bans in IndiaChirantan Chatterjee, Debi Prasad Mohapatra, Manuel Estay
Research Policy|September 21, 2020
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabelingMatthew J Higgins, Xin Yan, Chirantan Chatterjee
Health Economics|February 2, 2023
Movies, stigma and choice: Evidence from the pharmaceutical industryMayank Aggarwal, Anindya S Chakrabarti, Chirantan Chatterjee
Social Science & Medicine (1982)|December 31, 2019
Did India's price control policy for coronary stents create unintended consequences?Sarang Deo, Hanu Tyagi, Chirantan Chatterjee, et al.
Health Policy and Planning|February 17, 2017
Mitigating regulatory impact: the case of partial price controls on metformin in IndiaAjay Bhaskarabhatla, Chirantan Chatterjee, Priyatam Anurag, et al.
Social Science & Medicine (1982)|November 28, 2017
Government health insurance and spatial peer effects: New evidence from IndiaChirantan Chatterjee, Radhika Joshi, Neeraj Sood, et al.
Review of Development Economics|August 9, 2022
Pandemics and technology engagement: New evidence from m-Health intervention during COVID-19 in IndiaSawan Rathi, Anindya S Chakrabarti, Chirantan Chatterjee, et al.
Pageof 2